Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
36
results for
Pharmaceuticals
Filters
Refine your search
Excipients for injectable formulations. It is recommended for pharmaceutical applications like haemodialysis.Benefits:
- Acts as buffering agents/pH modifiers
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Buffering agent and pH modifier developed exclusively for use in injectable formulations.Benefits:
- DMF Filed - CDE # F20200000141
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Excipient developed for pharmaceutical applications. It is
used as a pH modifier and buffering agent in injectable formulations. Benefits:
- Complies with USP-NF specifications
- Helps to maintain a low level of endotoxins and metallic impurities
TDS
Solvent and co-solvent designed for injectable formulations.
This excipient is used as a buffering agent and pH modifier. Benefits:
- Highly pure, gives sweet taste
- Helps to maintain low level of endotoxins and metallic impurities
- Complies with CDMF, USP, Ph Eur specification
TDS
Solvent, buffering agent and pH modifier designed for
injectable formulations. This excipient is also used as a co-solvent in
pharmaceutical preparations.
Benefits:
- Highly pure syrupy liquid
- Helps to maintain low level of endotoxins and metallic impurities
- Complies with USP, Ph. Eur and BP specification
TDS
Solvent, buffering agent and pH modifier suitable for
injectable formulations. This excipient also acts as a co-solvent in
pharmaceutical preparations.Benefits:
- Highly pure syrupy liquid
- Complies with USP, Ph. Eur and BP specification
- Helps to maintain low level of endotoxins and metallic impurities
TDS
Excipient developed for pharmaceutical preparations. It is used
as a buffering agent and pH modifier in injectable formulations.
Benefits:
- Colorless syrupy liquid
- Helps to maintain low level of endotoxins and metallic impurities
- Complies with USP, Ph. Eur and BP specifications
TDS
Preservative specially developed for injectable formulations, solid and semi-solid dosage forms.Benefits:
- DMF Filed
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20190000639
TDS
Solvent/ Co-solvent and chelating agent developed exclusively for use in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
TDS
Solvent, co-solvent and chelating agent designed for
injectable formulations. Benefits:
- Helps to maintain low level of endotoxins and metallic impurities
- Compliant with USP and Ph. Eur
TDS
Excipients for injectable formulations. It is recommended for pharmaceutical applications.Benefits:
- Acts as buffering agents/pH modifiers
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
- It maintains low level of endotoxins with the bioburden limits- BET/MLT
- Controlled metallic impurities
- Developed for…
TDS
Excipient developed for injectable formulations. It functions as a preservative/antimicrobial. Benefits:
- Maintains a low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Antioxidant and reducing agent used in injectable formulations. t is an excipient designed for solid and semi-solid dosage forms. Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Actylis
Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and Agriscience industries.
